Antiarrhythmic effect of ischemic preconditioning in recent unstable angina patients undergoing coronary artery

Zhong-Kai Wu1, Tiina Iivainen, Erkki Pehkonen

  • 1Division of Cardiac Surgery, Department of Surgery, Tampere University Hospital, Teiskontie 35, 33521 Tampere, Finland.

World Journal of Surgery
|November 13, 2003
PubMed

Insights

Ischemic preconditioning (IP) significantly reduces postoperative arrhythmias in patients undergoing coronary artery bypass grafting (CABG). This myocardial protective strategy also shortens hospital stays for unstable angina patients.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Ischemia-Reperfusion Research

Background:

  • Coronary artery bypass grafting (CABG) in unstable angina patients is linked to increased arrhythmia and cardiac mortality.
  • Ischemic preconditioning (IP) is known to suppress ischemia-reperfusion arrhythmias in both animal and human studies.

Purpose of the Study:

  • To evaluate the protective effect of IP against postoperative arrhythmias in recent unstable angina patients undergoing urgent CABG.

Main Methods:

  • Forty-one patients with unstable angina and three-vessel coronary artery disease were randomized into IP and control groups.
  • The IP protocol involved two 2-minute aortic occlusions followed by 3-minute reperfusion periods.
  • Twenty-four-hour continuous electrocardiography (ECG) monitored patients preoperatively and for two days postoperatively.

Main Results:

  • IP significantly reduced the incidence of ventricular tachycardia (VT) and the severity of supraventricular extrasystole (SVES), ventricular extrasystole (VES), supraventricular tachycardia (SVT), and VT post-CABG.
  • Patients in the IP group experienced significantly shorter mechanical ventilation periods and intensive care unit (ICU) stays.
  • Postoperative arrhythmia rates for SVES, VES, SVT, and VT were substantially higher in the control group compared to the IP group.

Conclusions:

  • Rhythm disturbances are highly prevalent in CABG patients with recent unstable angina.
  • IP demonstrates significant efficacy in mitigating various rhythm disturbances, including SVES, VES, SVT, and VT, following CABG.
  • IP presents a promising additional myocardial protective strategy for unstable angina patients undergoing CABG.

Related Concept Videos